Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | MDGL | CORT | ||
| Company | Valeant Pharmaceuticals Intl | Madrigal Pharmaceuticals Inc | Corcept Therapeutics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 24.15 | 522.34 | 57.38 | ||
| High | 24.43 | 547.24 | 59.19 | ||
| Low | 23.36 | 518.32 | 56.18 | ||
| Latest | 23.40 | 539.89 | 58.30 | ||
| Change | -0.83 | +21.02 | +1.22 | ||
| % Change | -3.43% | +4.05% | +2.14% | ||
| Volume | 6,569,300 | 336,256 | 1,670,834 | ||
| 20-Day Average Volume | 6,685,200 | 285,023 | 1,247,012 | ||
| Previous Close | 24.23 | 518.87 | 57.08 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 520.27 | 49.44 | ||
| 20-Day Raw Stochastic | 18.46% | 72.25% | 94.02% | ||
| 20-Day Relative Strength | 52.09 | 57.46 | 74.83 | ||
| Weighted Alpha | +35.20 | +74.98 | +42.71 | ||
| Today's Opinion | N/A | 72% Buy | 8% Buy | ||
| Previous Opinion | N/A | 48% Buy | 8% Buy | ||
| Last Month's Opinion | N/A | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | +0.94% since 05/07/26 | +14.20% since 05/07/26 | ||
| Low | 23.02 on 07/09/18 | 490.13 on 05/12/26 | 50.32 on 05/08/26 | ||
| High | 24.43 on 07/13/18 | 547.24 on 05/14/26 | 59.19 on 05/14/26 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | +2.84% since 04/14/26 | +33.47% since 04/14/26 | ||
| Low | 22.56 on 06/28/18 | 490.13 on 05/12/26 | 43.20 on 04/16/26 | ||
| High | 27.25 on 06/14/18 | 559.00 on 05/06/26 | 59.19 on 05/14/26 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | +16.18% since 02/13/26 | +45.86% since 02/13/26 | ||
| Low | 16.76 on 04/16/18 | 416.21 on 03/03/26 | 28.66 on 02/19/26 | ||
| High | 27.79 on 06/13/18 | 572.20 on 03/26/26 | 59.19 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +2.02% since 11/14/25 | -22.82% since 11/14/25 | ||
| Low | 14.44 on 03/02/18 | 416.21 on 03/03/26 | 28.66 on 02/19/26 | ||
| High | 27.79 on 06/13/18 | 615.00 on 12/24/25 | 89.00 on 12/15/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 11,963,061 | 6,127,652 | ||
| Shares Outstanding, K | 348,710 | 23,056 | 107,352 | ||
| Annual Sales | 8,724,000,000 | 958,400,000 | 761,410,000 | ||
| Annual Net Income | 2,404,000,000 | -288,280,000 | 99,650,000 | ||
| Last Quarter Sales | 1,995,000,000 | 311,340,000 | 164,900,000 | ||
| Last Quarter Net Income | -2,693,000,000 | -94,390,000 | -31,760,000 | ||
| 60-Month Beta | -0.38 | -1.04 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -3.25 on 05/06/26 | -0.30 on 04/30/26 | ||
| Earnings Date | 08/14/18 | 08/04/26 | 07/30/26 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 146.17 | ||